InternationalUSRemember you can easily switch between MIP US and MIP International at any time

UPC scenario 2: a blockbuster drug patent with an SPC

Managing Intellectual Property


In our second discussion of a hypothetical UPC scenario, Duncan Ribbons and Rebecca Lawrence address some of the complications that arise with SPCs, licences, opt outs and injunctions

The Unified Patent Court (UPC) promises to herald a new dawn for patent litigation in Europe. Pan-European injunctions and central revocation will become normal, whereas under the current system injunctions and revocations must be obtained on a country-by-country basis. However,...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Our weekly IP news round-up includes NPEs in Europe, AI, sovereign immunity, Section 101, UK trade secrets, and the… https://t.co/1IKhZLv7Gl

Feb 22 2018 03:46 ·  reply ·  retweet ·  favourite
ManagingIP profile

German Constitutional Court plans to decide UPC case in 2018 https://t.co/HURPYcerwS But it is not certain a decisi… https://t.co/pQugzgEtRt

Feb 22 2018 02:04 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @UPCtracker: This is one of nine (9) cases allocated to Justice Prof Huber (among them consolidated complaint re: adequate legal protect…

Feb 21 2018 05:15 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

February 2018

FRAND aid: Is the European Commission’s SEP guidance useful?

Both patent owners and implementers have welcomed the European Commission’s communication on standard essential patents. Does that mean it has successfully balanced competing interests or merely dodged the difficult questions? James Nurton investigates



Most read articles

Supplements